![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Department of Pharmacology and Toxicology, Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada
Received February 27, 2006; accepted May 22, 2006.
| Abstract |
|---|
|
|
|---|
Although the GSTs are found primarily in the cytosol as homodimers or heterodimers, a membrane-bound GST (MGST1) that accounts for up to 3% of microsomal protein also has been identified (Morgenstern et al., 1982
). The MGST1 is a member of the membrane-associated proteins in eicosanoid and glutathione metabolism superfamily of proteins, and although classified as a glutathione S-transferase, this GST isoform bears no obvious structural resemblance (amino acid sequence, molecular weight, or immunological properties) to the cytosolic GSTs.
Most previous studies have focused on the role of the cytosolic GSTs in the biotransformation of GTN (Habig et al., 1975
; Posadas del Rio et al., 1988
; Tsuchida et al., 1990
; Kurz et al., 1993
; Nigam et al., 1996
). However, the GSH-dependent biotransformation of GTN in hepatic microsomes also occurs (Lau and Benet, 1990
), suggesting a role for MGST1 in GTN biotransformation. The interpretation of microsomal biotransformation studies is complicated by the association of certain cytosolic GST isoforms with the microsomal fraction (Morgenstern et al., 1983
; Hayes et al., 2005
), and there is little information regarding the specific role of MGST1 in GTN biotransformation. A characteristic of rat liver MGST1 is that covalent modification (e.g., alkylation by N-ethylmaleimide) of its single cysteine residue (Cys-49) results in a marked increase in enzyme activity. Oxidative modification of Cys-49 also results in increased enzyme activity, and recent data from our laboratory have demonstrated that in addition to oxidative stress, nitrosative stress increases MGST1 activity by tyrosine nitration of Tyr-92 and, to a lesser extent, by nitrosation of Cys-49 (Ji et al., 2002
, 2006
; Ji and Bennett, 2003
). In the present study, our goal was to compare GTN biotransformation by the microsomal and cytosolic GSTs to assess the effect of various modifications of MGST1 on GTN biotransformation and to assess whether MGST1 activity or expression is altered in GTN-tolerant animals.
| Materials and Methods |
|---|
|
|
|---|
-[32P]dCTP (specific activity of 6000 Ci/mmol) were from GE Healthcare (Baie d'Urefe, QC, Canada). The 18 S ribosomal RNA DECA probe template was purchased from Ambion (Austin, TX). All other chemicals were of reagent grade and were obtained from a variety of commercial sources.
Induction of GTN Tolerance in Vivo. All procedures for animal experimentation were undertaken in accordance with the principles and guidelines of the Canadian Council on Animal Care. GTN tolerance was induced in male Sprague-Dawley rats (250300 g) by exposing animals to a continuous source of GTN via the subdermal implantation of two 0.2 mg/h transdermal GTN patches (tolerant) or drug-free patches (control) for 48 h as described previously (Ratz et al., 2000a
). In brief, rats were anesthetized with halothane, a 1-cm transverse incision was made in the upper dorsal region, and the site was disinfected with 2.5% iodine. The skin was separated from the underlying fascia by blunt dissection, and two transdermal patches were inserted back-to-back into the resulting subdermal space. The site was sutured closed and disinfected again with iodine. At 24 h, the site was reopened and both patches were replaced, and at 48 h livers and/or aortae were harvested.
Synthesis of GSNO and Peroxynitrite. GSNO was prepared by reacting equimolar concentrations of sodium nitrite and GSH as described previously (Ji et al., 1996
). The concentration of GSNO was determined spectrophotometrically at 334 nm (
= 767 M1 cm1). Peroxynitrite was synthesized from acidified nitrite and H2O2 as described by Beckman et al. (1994
) and stored at 70°C. The concentration of peroxynitrite was determined spectrophotometrically at 302 nm (
= 1670 M1 cm1) at the time of synthesis and again just before use. The H2O2 contamination of peroxynitrite solutions was removed by manganese dioxide chromatography and filtration (Beckman et al., 1994
).
Measurement of Microsomal Lipid Peroxidation. Lipid peroxidation products in hepatic microsomes from control and GTN-tolerant rats were determined spectrophotometrically at 532 nm (
= 1.56 x 105 M1 cm1) as thiobarbituric acid-like reactive substances (TBARS) (Aust, 1985
).
Isolation of Rat Liver Microsomes and Purification of MGST1. Rat hepatic or aortic microsomes were prepared as described previously (McDonald and Bennett, 1993
; Ji et al., 1996
). Microsomes were washed twice with 100 mM Tris-HCl (pH 7.4) to decrease cytosolic contamination and then stored at 70°C. Hepatic MGST1 was purified by hydroxyapatite and CM-Sepharose chromatography by the method of Morgenstern and DePierre (1983
) as described in Ji and Bennett (2003
). GST activity was determined using the method of Habig et al. (1974
). Samples (1.0 ml) contained 100 mM potassium phosphate, pH 6.5, 1 mM GSH, and 1 mM CDNB at 25°C. For the assay of MGST1 or microsomal fractions, 0.5% Triton X-100 was added to the incubation buffer.
GTN Biotransformation Studies. Chemical modification of cytosolic GSTs or MGST1 was performed by incubation of enzyme in 100 mM potassium phosphate (pH 7.0) with 1.0 mM NEM for 1 min or 2 mM peroxynitrite for 10 s at room temperature and with 2 mM GSNO for 10 min or 5 mM H2O2 for 30 min at 37°C (Aniya and Anders, 1992
; Ji et al., 2002
; Ji and Bennett, 2003
). To assess GTN biotransformation, 5 µg of purified cytosolic GSTs or MGST1 was incubated with the indicated concentrations of GTN and 1 mM GSH at 37°C for 60 min in a final volume of 0.5 ml. Some samples were pretreated with 1 mM NEM before assessment of GTN biotransformation. The GTN metabolites, 1,2-GDN and 1,3-GDN, were quantitated by gas chromatography with electron capture detection as described previously (McDonald and Bennett, 1990
). Denitration rates were corrected for the nonenzymatic formation of GDNs (
5% of total metabolites)
SDS-PAGE and Immunoblot Analysis. Rat liver and aortic microsomes from control and GTN-tolerant animals were resolved on a 15% SDS-PAGE gel under nonreducing conditions. Proteins were transferred electrophoretically to PVDF membranes and then incubated with specific antiserum against rat liver MGST1 (1:5000). The immunoreactive protein bands were visualized by enhanced chemiluminescence.
Northern Analysis. Total tissue RNA was isolated from rat liver or aorta using QIAGEN RNeasy spin columns according to the manufacturer's recommendations. Total RNA (1020 µg) was resolved on 1% agarose gels containing 1.1% formaldehyde and was transferred to nylon membranes (Hybond N+) by overnight capillary blotting. Membranes were prehybridized in QuikHyb solution for 30 min at 68°C and then hybridized for 2 h at 68°C with cDNA probes 32P-radiolabeled with [32P]dCTP (6000 Ci/mmol) by random priming. The 599-base pair MGST1 cDNA probe was generated by an reverse transcription-polymerase chain reaction procedure using rat liver as the source of RNA. Membranes were exposed to a phosphor storage screen at 70°C for 2 h, scanned with a Bio-Rad Molecular Imager FX (Bio-Rad Laboratories Ltd, Mississauga, ON, Canada) and quantitated using Corel Photo-Paint version 8 software. After quantitation of MGST1 mRNA, membranes were stripped and reprobed with an 18 S rRNA probe to correct for variations in RNA loading.
Data Analysis. Data were analyzed by the appropriate statistical test as indicated. A p value of
0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
Hepatic Microsomal and Cytosolic GST Activities in GTN-Tolerant Animals. To determine whether chronic exposure to GTN results in changes in hepatic GST activity, we assessed enzyme activity in subcellular fractions of the livers from naive and GTN-tolerant animals. For the cytosolic fraction, activity toward both CDNB and GTN was reduced by
25% in preparations from GTN-tolerant animals. In contrast, GTN biotransformation was unaltered in microsomes from GTN-tolerant animals, and activity in control and tolerant microsomes was inhibited to the same degree after treatment of microsomes with NEM (Table 2). With CDNB as substrate, however, enzyme activity was increased >2-fold in microsomes from GTN-tolerant animals, although the maximal activation after treatment of microsomes with NEM was the same for the two microsomal preparations. Because it has been suggested that oxidative/nitrosative stress occurs in GTN tolerance, one might predict that there would be increased lipid peroxidation as a consequence of chronic GTN exposure. We assessed the level of lipid peroxidation, as measured by TBARS levels, and found no difference between microsomes from naive and GTN-tolerant animals (0.20 ± 0.05 and 0.18 ± 0.04 nmol of TBARS/mg protein, respectively, p > 0.05, unpaired t test, n = 3).
|
Immunoblot and Northern Analysis of MGST1. Immunoblot and Northern blot analyses were performed to determine whether chronic exposure to GTN resulted in changes in MGST1 expression. The data in Figs. 2 and 3 indicate that the hepatic MGST1 was down-regulated only at the mRNA level in GTN-tolerant animals. There was an
60% reduction in mRNA levels, whereas the levels both the monomeric and dimeric forms of the enzyme were essentially unchanged. We also assessed MGST1 protein in aortic microsomes and found that there was a reduction in the dimeric form of the enzyme in microsomes from GTN-tolerant animals and also a reduction in the levels of MGST1 trimer. However, in contrast to the data from liver, there was an increase in the levels of MGST1 monomer in aortic microsomes from GTN-tolerant animals. The levels of aortic MGST1 mRNA from GTN-tolerant animals were somewhat variable, and although the average level of expression was doubled, this increase was not statistically significant.
|
|
| Discussion |
|---|
|
|
|---|
Both enzyme preparations exhibited regioselectivity for GTN denitration, with selective formation of the 1,3-GDN metabolite. Treatment of the cytosolic GSTs with the alkylating agent NEM resulted in a decrease in GTN denitration (Fig. 1, A and B) and a parallel decrease in the enzyme activity toward CDNB (Table 1). However, in marked contrast to the increase in MGST1 activity toward CDNB after alkylation of Cys-49 by NEM (Table 1), the GTN denitration activity of MGST1 activity toward GTN was inhibited markedly by NEM (Fig. 1, A and B).
Activation of MGST1 by covalent modification of Cys-49 is a characteristic that distinguishes the microsomal GST from its cytosolic counterparts (Morgenstern and DePierre, 1983
). The MGST1 is thought to exist as a homotrimer in the native state. The trimer binds one molecule of GSH and altered communication between subunits is believed to play a role in enzyme activation by agents such as NEM. The formation of the thiolate consists of fast and slow components, with rapid binding of GSH followed by slower formation of thiolate (Svensson et al., 2004
). Modification of Cys-49 by NEM increases the rate of thiolate formation and increases kcat. The activation of MGST1 by NEM with respect to CDNB conjugation is in marked contrast to the inhibition of GTN biotransformation after alkylation of the enzyme with NEM and suggests a differential interaction of the two substrates with the enzyme. In previous studies examining the kinetic properties of the NEM-activated enzyme, it was found that an increase in the rate of catalysis occurred only with certain substrates and that with others it was unaltered and that this was related to the relative reactivity of substrate (Morgenstern and DePierre, 1983
; Morgenstern et al., 1988
). Although GTN is a substrate for the enzyme, the specific activity for denitration is quite low compared with the rate of the conjugation reaction with CDNB. However, this lower specific acivity would not explain the observed decrease in enzyme activity after treatment with NEM.
|
Tolerance to GTN after chronic exposure in vivo is associated with attenuation of the vasodilator responses to GTN and also decreases in the vascular biotransformation of GTN (Ratz et al., 2000a
). In addition, the pattern of GTN metabolite formation in the whole animal is altered in GTN-tolerant animals (Ratz et al., 2002
). To assess whether chronic GTN exposure might alter the contribution of MGST1 to the overall biotransformation of GTN, we compared the activity and expression of MGST1 in hepatic microsomes from naive and GTN-tolerant animals. The levels of MGST1 mRNA were significantly reduced in the livers of GTN-tolerant animals, although the level of expression of MGST1 protein was unchanged (Figs. 2 and 3). However, the levels of MGST1 protein did not correlate well with enzyme activity toward CDNB. With respect to GTN, there was no change in the rate of metabolite formation whereas for CDNB conjugation, GST activity was actually increased despite the fact that MGST1 protein expression was unchanged. This finding suggests that the chronic exposure to GTN resulted in some sort of structural or conformational change in the enzyme that resulted in an increase in catalytic activity toward CDNB but not to GTN. An alternative explanation could be that the expression of microsome-associated cytosolic GSTs is increased during chronic GTN exposure and that this increase accounts for the increase in GST activity. It is noteworthy that the expression of the class Alpha GST present in human hepatic microsomes is increased after exposure of cultured human hepatoblastoma (HepG2) cells to the prooxidant, hydrogen peroxide (Prabhu et al., 2004
). With respect to the cytosolic GSTs, biotransformation of GTN was decreased in the hepatic cytosolic fraction from GTN-tolerant animals, as was the enzyme activity of the cytosol toward CDNB. A similar degree of inhibition of CDNB conjugation was found after incubation of purified enzyme preparations with GTN (Lee and Fung, 2003
).
As was observed with the purified MGST1, treatment of hepatic microsomes with NEM markedly inhibited GTN denitration, and this occurred to a similar extent in microsomes from control and GTN-tolerant animals. In contrast, in a previous study it was found that incubation of hepatic microsomes with the alkyl nitrites, amyl nitrite and n-butyl nitrite, resulted in the formation of GSNO, and that treatment of microsomes with NEM increased the rate of GSNO formation (Ji et al., 1996
). These data suggest that subtle changes in substrate structure have profound effects on catalysis by MGST1 and that the interaction of organic nitrites and organic nitrates with MGST1 is fundamentally different.
It was not technically feasible to generate sufficient quantities of aortic microsomes to assess changes in MGST activity. However, we were able to assess changes in aortic MGST1 expression after chronic GTN exposure. In contrast to the findings in liver, mRNA levels were unchanged in aortae from GTN-tolerant animals and levels of the MGST1 monomer were increased rather than unchanged (Figs. 4 and 5). In situ, MGST1 is thought to exist as a homotrimer (Lundqvist et al., 1992
), although on both reducing and nonreducing SDS-PAGE gels the enzyme migrates primarily as the 17-kDa monomer. As seen in the immunoblots of hepatic and aortic microsomes from naive animals, immunoreactive bands are evident at mobilities consistent with MGST1 dimers, and in the aorta as trimers as well, suggesting that a proportion of monomers are covalently linked to one another. However, in aortic microsomes from GTN-tolerant animals, there was a clear reduction in the dimeric and trimeric forms of the enzyme as seen on SDS-PAGE gels. The functional significance of this finding is uncertain, but the observation that the relative proportions of the enzyme in dimeric or trimeric forms is altered suggests that chronic exposure to GTN changes the association properties of the MGST1 monomer.
|
Using the data in Table 1, we derived a kcat/Km value for GTN of 754 M1·S1 for MGST1 and 263 M1·S1 for the cytosolic GST mixture, approximately a 3-fold difference. In comparison, the kcat/Km values for rat hepatic cytochromes P450-mediated GTN biotransformation in hepatic microsomes under aerobic and anaerobic conditions are 390 and 14,000 M1 · S1, respectively (McDonald and Bennett, 1990
), and that for purified recombinant human aldehyde dehydrogenase-2 (Li et al., 2006
) is 1390 M11 · S1. Thus, the catalytic efficiencies of four enzymes known to biotransform GTN are within a 5-fold range of each other (with the exception of cytochromes P450 under anaerobic conditions).
With respect to the overall quantitative contribution of these enzymes to GTN biotransformation, this also would be significantly influenced by the relative abundance of different biotransformation enzymes in a particular tissue. Microsomal protein accounts for
20% of the protein in rat hepatocytes (DePierre and Dallner, 1975
) and MGST1 comprises
3% of microsomal protein (Morgenstern et al., 1982
). On the other hand, the cytosolic GSTs make up
5% of the cytosolic protein, and, thus, if one takes into account the higher activity but lower abundance of the MGST1 versus the lower activity and higher abundance of the cytosolic GSTs, the relative contributions would be within a 2-fold range of each other. The cytochromes P450 content of microsomes is approximately double that of MGST1 and the kcat/Km value (under aerobic conditions) is approximately half, and therefore their relative contribution would be approximately the same as that of MGST1. However, because GTN biotransformation by cytochromes P450 is markedly greater under anaerobic conditions, the relative contribution of cytochromes P450 would be expected to be sensitive to changes in the intracellular O2 concentration. Mitochondrial protein accounts for
7% of rat hepatocyte protein (Colbeau et al., 1971
), and although ALDH2 has a relatively high kcat/Km value, its abundance would be low because of its mitochondrial location. There are other factors that complicate extrapolation of enzyme reaction rates to the in vivo situation. The lipophilic nature of GTN would predict its preferential subcellular distribution to membranes and thus better access to membrane-bound biotransformation enzymes, and, in addition, the rate of GTN biotransformation is markedly reduced in broken cell preparations compared with that in intact cells (Bennett et al., 1994
). With respect to the functional significance of MGST1-mediated GTN biotransformation, we have found that in a stably transfected cell line that overexpresses rat MGST1, there was an increase in GTN-induced cGMP formation compared with wild-type cells, suggesting that the MGST1 can mediate the mechanism-based biotransformation of GTN to an activator of guanylyl cyclase (Y. Ji and B. M. Bennett, unpublished observations).
In summary, we have demonstrated that MGST1 can catalyze the denitration of GTN and that it does so with greater efficiency than its cytosolic counterparts. Chemical modification of MGST1 has differential effects on the catalytic activity toward different substrates, and chronic GTN exposure seems to cause structural modifications to the enzyme that, although having no effect on the biotransformation of GTN, result in increased activity toward other MGST1 substrates.
| Acknowledgements |
|---|
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
ABBREVIATIONS: GTN, glyceryl trinitrate; NO, nitric oxide; GDN, glyceryl dinitrate; GST, glutathione S-transferase; MGST1, microsomal glutathione S-transferase 1; GSH, reduced glutathione; CDNB, 1-chloro-2,4-dinitrobenzene; NEM, N-ethylmaleimide; GSNO, S-nitrosoglutathione; TBARS, thiobarbituric acid-like reactive substance(s); PAGE, polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; ALDH2, aldehyde dehydrogenase-2.
Address correspondence to: Dr. Brian M. Bennett, Department of Pharmacology and Toxicology, Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada K7L 3N6. E-mail: brian.bennett{at}queensu.ca
| References |
|---|
|
|
|---|
Aniya Y and Anders MW (1992) Activation of rat liver microsomal glutathione S-transferase by hydrogen peroxide: role for protein-dimer formation. Arch Biochem Biophys 296: 611616.[CrossRef][Medline]
Aust SD (1985) Lipid peroxidation, in CRC Handbook of Methods for Oxygen Radical Research (Greenwald RA ed) pp 203207, CRC Press, Inc., Boca Raton, FL.
Beckman JS, Chen J, Ischiropoulos H, and Crow JP (1994) Oxidative chemistry of peroxynitrite. Methods Enzymol 233: 229240.[Medline]
Bennett BM, Kobus SM, Brien JF, Nakatsu K, and Marks GS (1986) Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate. J Pharmacol Exp Ther 237: 629635.
Bennett BM, McDonald BJ, Nigam R, and Simon WC (1994) Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends Pharmacol Sci 15: 245249.[CrossRef][Medline]
Chen Z, Zhang J, and Stamler JS (2002) Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 99: 83068311.
Colbeau A, Nachbaur J, and Vignais PM (1971) Enzymic characterization and lipid composition of rat liver subcellular membranes. Biochim Biophys Acta 249: 462492.[Medline]
DePierre JW and Dallner G (1975) Structural aspects of the membrane of the endoplasmic reticulum. Biochim Biophys Acta 415: 411472.[Medline]
Doel JJ, Godber BL, Goult TA, Eisenthal R, and Harrison R (2000) Reduction of organic nitrites to nitric oxide catalyzed by xanthine oxidase: possible role in metabolism of nitrovasodilators. Biochem Biophys Res Commun 270: 880885.[CrossRef][Medline]
Habig WH, Keen JH, and Jakoby WB (1975) Glutathione S-transferase in the formation of cyanide from organic thiocyanates and as an organic nitrate reductase. Biochem Biophys Res Commun 64: 501506.[CrossRef][Medline]
Habig WH, Pabst MJ, and Jacoby WB (1974) Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 249: 71307139.
Hayes JD, Flanagan JU, and Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 5188.[CrossRef][Medline]
Ji Y, Akerboom TPM, and Sies H (1996) Microsomal formation of S-nitrosoglutathione from organic nitrites: possible role of membrane-bound glutathione transferase. Biochem J 313: 377380.
Ji Y and Bennett BM (2003) Activation of rat liver microsomal glutathione S-transferase by peroxynitrite. Mol Pharmacol 63: 136146.
Ji Y, Neverova I, Van Eyk JE, and Bennett BM (2006) Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione S-transferase by peroxynitrite. J Biol Chem 281: 19861991.
Ji Y, Toader V, and Bennett BM (2002) Regulation of microsomal and cytosolic glutathione S-transferase activities by S-nitrosylation. Biochem Pharmacol 63: 13971404.[CrossRef][Medline]
Kurz MA, Boyer TD, Whalen R, Peterson TE, and Harrison DG (1993) Nitroglycerin metabolism in vascular tissue: role of glutathione S-transferase and relationship between NO· and NO2 formation. Biochem J 292: 545550.
Lau DT-W and Benet LZ (1990) Nitroglycerin metabolism in subcellular fractions of rabbit liver: dose dependency of glyceryl dinitrate formation and possible involvement of multiple isozymes of glutathione S-transferases. Drug Metab Dispos 18: 292297.[Abstract]
Lee W-I and Fung H-L (2003) Mechanism-based partial inactivation of glutathione S-transferases by nitroglycerin: tyrosine nitration vs sulfhydryl oxidation. Nitric Oxide 8: 103110.[CrossRef][Medline]
Li Y, Zhang D, Jin W, Shao C, Yan P, Xu C, Sheng H, Liu Y, Yu J, Xie Y, et al. (2006) Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Investig 116: 506511.[CrossRef][Medline]
Lundqvist G, Yucel-Lindberg T, and Morgenstern R (1992) The oligomeric structure of rat liver microsomal glutathione transferase studied by chemical cross-linking. Biochim Biophys Acta 1159: 103108.[CrossRef][Medline]
McDonald BJ and Bennett BM (1990) Cytochrome P-450-mediated biotransformation of organic nitrates. Can J Physiol Pharmacol 68: 15521557.[Medline]
McDonald BJ and Bennett BM (1993) Biotransformation of glyceryl trinitrate by rat aortic cytochrome P450. Biochem Pharmacol 45: 268270.[CrossRef][Medline]
McGuire JJ, Anderson DJ, McDonald BJ, Narayanasami R, and Bennett BM (1998) Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate. Biochem Pharmacol 56: 881893.[CrossRef][Medline]
Meah Y, Brown BJ, Chakraborty S, and Massey V (2001) Old yellow enzyme: reduction of nitrate esters, glycerin trinitrate, and propylene 1,2-dinitrate. Proc Natl Acad Sci USA 98: 85608565.
Morgenstern R and DePierre JW (1983) Microsomal glutathione transferase: purification in unactivated form and further characterization of the activation process, substrate specificity and amino acid composition. Eur J Biochem 134: 591597.[Medline]
Morgenstern R, Guthenberg C, and DePierre JW (1982) Microsomal glutathione S-transferase: purification, initial characterization and demonstration that it is not identical to the cytosolic glutathione S-transferase A, B and C. Eur J Biochem 128: 243248.[Medline]
Morgenstern R, Guthenberg C, Mannervik B, and DePierre JW (1983) The amount and nature of glutathione transferases in rat liver microsomes determined by immunochemical methods. FEBS Lett 160: 264268.[CrossRef][Medline]
Morgenstern R, Lundqvist G, Hancock V, and DePierre JW (1988) Studies on the activity and activation of rat liver microsomal glutathione transferase, in particular with a substrate analogue series. J Biol Chem 263: 66716675.
Nigam R, Anderson DJ, and Bennett BM (1996) Isoform-specific biotransformation of glyceryl trinitrate by rat aortic glutathione S-transferases. J Pharmacol Exp Ther 279: 15271534.
Posadas del Rio FA, Juarez FJ, and Garcia RC (1988) Biotransformation of organic nitrate esters in vitro by human liver, kidney, intestine and blood serum. Drug Metab Dispos 15: 477481.
Prabhu KS, Reddy PV, Jones EC, Liken AD, and Reddy CC (2004) Characterization of a class alpha glutathione-S-transferase with glutathione peroxidase activity in human liver microsomes. Arch Biochem Biophys 424: 7280.[CrossRef][Medline]
Ratz JD, Adams MA, and Bennett BM (2002) Effect of in vivo nitrate tolerance on the hypersensitivity to NO-donors after NO-synthase blockade. Can J Physiol Pharmacol 80: 11061118.[CrossRef][Medline]
Ratz JD, Fraser AB, Rees-Milton KJ, Adams MA, and Bennett BM (2000a) Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat. J Pharmacol Exp Ther 295: 578585.
Ratz JD, McGuire JJ, Anderson DJ, and Bennett BM (2000b) Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat. J Pharmacol Exp Ther 293: 569577.
Svensson R, Alander J, Armstrong RN, and Morgenstern R (2004) Kinetic characterization of thiolate anion formation and chemical catalysis of activated microsomal glutathione transferase 1. Biochemistry 43: 88698877.[CrossRef][Medline]
Tsuchida S, Maki J, and Sato K (1990) Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart: Multiplicity of the human class mu forms. J Biol Chem 265: 71507157.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||